CN109876142A - β2受体激动剂的医药应用 - Google Patents

β2受体激动剂的医药应用 Download PDF

Info

Publication number
CN109876142A
CN109876142A CN201711272977.9A CN201711272977A CN109876142A CN 109876142 A CN109876142 A CN 109876142A CN 201711272977 A CN201711272977 A CN 201711272977A CN 109876142 A CN109876142 A CN 109876142A
Authority
CN
China
Prior art keywords
drug
seasonal
present
receptor agonist
medical applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711272977.9A
Other languages
English (en)
Inventor
程淑清
牛清玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shaanxi Xiu Feng Biological Technology Co Ltd
Original Assignee
Shaanxi Xiu Feng Biological Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shaanxi Xiu Feng Biological Technology Co Ltd filed Critical Shaanxi Xiu Feng Biological Technology Co Ltd
Priority to CN201711272977.9A priority Critical patent/CN109876142A/zh
Publication of CN109876142A publication Critical patent/CN109876142A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明涉及β2受体激动剂的医药应用,在制备预防季节性咳嗽发作的药物的方面的应用。本发明药物是通过口腔吸入达到局部给药的目的,与全身给药相比,药量小,副作用小,效果明显。经50位由于过敏体质导致的季节性咳嗽的患者使用后,在过敏季节来临前一个月,开始吸入本发明药物,每天吸两次,吸两个月,有45位患者在过敏季节都没有季节性咳嗽发作,有5位患者有轻微的咳痰的症状,但无明显的季节性咳嗽发作迹象,显效率达90%,有效率达100%。

Description

β2受体激动剂的医药应用
技术领域
本发明涉及一种β2受体激动剂的医药应用.
背景技术
过敏体质导致的季节性咳嗽通常是有季节性的,一般是在春季和夏末秋初的季节,患者往往是对这两个季节的某一植物的药粉过敏,导致过敏性哮喘或者季节性咳嗽,症状大概会持续一个月左右。
短效β2受体激动剂中常用的有沙丁胺醇和特布他林。吸入给药,包括气雾剂、干粉剂和雾化溶液,可直接作用于支气管平滑肌。其平喘作用快,通常数分钟内起效,疗效可维持4~6小时,是缓解哮喘急性症状的首选药物,也可作为运动性哮喘的预防药物。药物过量或不良反应包括心悸、骨骼肌震颤、心律紊乱和低血钾症等,应按需使用。沙丁胺醇每次吸入100~200微克;特布他林每次吸入250~500微克,但不宜长期单一使用。若1天用量超过4次或每月用量≥2罐气雾剂时应在医师指导下使用或调整用药。对症状较轻的病例也可采用口服给药的方法。长期应用短效β2受体激动剂(包括吸入和口服)可造成药物疗效下降,停药一段时间后才可恢复。长效β2受体激动剂的作用强而持久,每次用药可达10~12小时,与糖皮质激素联用可减少后者用量,具有协同作用,还不易产生耐药性,对心血管作用极少。
发明内容
本发明要解决的技术问题是提供β2受体激动剂在制备预防季节性咳嗽发作方面的药物的应用。
为了解决现有技术存在的问题,本发明采用的技术方案是:
β2受体激动剂在制备用于预防过敏性季节性咳嗽的发作的药物。
本发明所具有的优点与效果是:
本发明药物是通过口腔吸入达到局部给药的目的,与全身给药相比,药量小,副作用小,效果明显。经50位由于过敏体质导致的季节性咳嗽的患者使用后,在过敏季节来临前一个月,开始吸入本发明药物,每天吸两次,吸两个月,有45位患者在过敏季节都没有季节性咳嗽发作,有5位患者有轻微的咳痰的症状,但无明显的季节性咳嗽发作迹象,显效率达90%,有效率达100%。
具体实施方式
实施例
β2受体激动剂可用于预防过敏性季节性咳嗽的发作,其应用方法是:在过敏季节到来的前一个月,开始吸入β2受体激动剂,每天两次,春节过敏的患者可以吸两个月,对于秋季过敏的患者可以吸到白露这一节气即可停吸,这样就可以预防过敏性季节性咳嗽发作。

Claims (1)

1.β2受体激动剂的医药应用,其特征在于在制备预防季节性咳嗽发作的药物的方面的应用。
CN201711272977.9A 2017-12-06 2017-12-06 β2受体激动剂的医药应用 Pending CN109876142A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711272977.9A CN109876142A (zh) 2017-12-06 2017-12-06 β2受体激动剂的医药应用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711272977.9A CN109876142A (zh) 2017-12-06 2017-12-06 β2受体激动剂的医药应用

Publications (1)

Publication Number Publication Date
CN109876142A true CN109876142A (zh) 2019-06-14

Family

ID=66923313

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711272977.9A Pending CN109876142A (zh) 2017-12-06 2017-12-06 β2受体激动剂的医药应用

Country Status (1)

Country Link
CN (1) CN109876142A (zh)

Similar Documents

Publication Publication Date Title
US11583519B2 (en) Nasal compositions and method of use thereof
NO334441B1 (no) Preparat for behandling av vanlig forkjølelse.
JPS62500789A (ja) ビタミンb↓1↓2含有経鼻組成物
MX2010013567A (es) Biopolimeros marinos antialergicos.
KR20190109310A (ko) 레반을 함유하는 염증성 질환 치료용 경비투여형 스프레이 제제
KR20130060092A (ko) 아로마에센셜오일 및 천연추출물의 다중약물발산조절층 구조를 갖는 천식 및 비염완화 하이드로겔 패취 조성물
CN109876142A (zh) β2受体激动剂的医药应用
CN105687222A (zh) 一种药物组合物在制备治疗支气管哮喘的药物中的应用
Pedersen et al. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis
WO2020031148A1 (en) Pharmaceutical composition, medicinal product and method of treatment of bronchopulmonary obstructive diseases
CN101829154B (zh) 防治哮喘的药物组合物的制备方法
CA2506962A1 (en) Synergistic combination comprising roflumilast and formoterol
CN1186659A (zh) 复方透皮吸收戒烟贴片
CN103432492A (zh) 一种治疗慢性支气管炎的中药
Ghaleb et al. The efficacy of licorice gargle for attenuating postoperative sore throat
WO2007054958A1 (en) A stable formulation for treatment of respiratory disorder
Coskun et al. Gelfoam injection as a treatment for temporary vocal fold paralysis
CN109875986A (zh) 肥大细胞膜稳定剂在预防皮炎发作方面的医药应用
CN109528708A (zh) 山奈酚在制备治疗鼻炎药物中的应用
CN1274360C (zh) 一种消炎止咳散剂
Frew et al. Effects of 4-week treatment with low-dose budesonide (100 μg BID) from a novel inhaler AirmaxTM and from a conventional inhaler on bronchial hyper-responsiveness, lung function and symptoms in patients with mild asthma
CN112933122B (zh) 一种治疗复发性口腔溃疡的中药外用药物
CN101991582A (zh) 布地奈德福莫特罗粉吸入剂的医药应用
Meenan et al. Common Vocal Remedies: What Are They and Do They Really Work?, Part 2
CN106138594A (zh) 一种防治激素依赖型哮喘的中药组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190614

WD01 Invention patent application deemed withdrawn after publication